natural glp-1 inhibitor GLP-1-based therapies for diabetes, obesity and beyond GLP-1 receptor agonists and next-generation

Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, et al

It's an exciting time, and our team is proud to support the researchers at the forefront by providing a comprehensive catalog of high-purity compounds, from foundational peptides to cutting-edge molecules

In the eating behavior sub-study, 31 of 36 retatrutide-treated participants reported noticeable changes in eating behaviors within the first 8 weeks

Associate Professor Natcha Thawesaengskulthai, Vice President for Strategic Planning, Innovation and Global Engagement of the Chulalongkorn University

In February 2025, the FDA declared that the shortage was over